NEW YORK, Dec. 11, 2020
/PRNewswire/ -- Longevity Acquisition Corporation (NASDAQ: LOAC)
(the "Company"), a publicly-traded special purpose acquisition
company, announced today that on December
10, 2020, the Company received a letter from the Listing
Qualifications Department of The NASDAQ Stock Market ("Nasdaq"),
confirming that the Company had regained compliance with Nasdaq
Listing Rule 5550(a)(3) which requires companies listed on the
NASDAQ Capital Market to have at least 300 public holders for
continued listing (the "Minimum Public Holders Rule").
As previously disclosed by the Company in its Current Report on
Form 8-K dated September 2, 2020, the
Company was notified by Listing Qualification Department of Nasdaq
that it did not comply with the Minimum Public Holders Rule. Based
on the Company's submissions to Nasdaq dated October 12, October
28 and November 30, 2020, the
Company had more than 300 public holders. Accordingly, the Listing
Qualifications Department of Nasdaq has determined that the Company
regained compliance with the Minimum Public Holders Rule.
About LOAC
LOAC is a blank check company, also commonly referred to as a
Special Purpose Acquisition Company, or SPAC, formed for the
purpose of acquiring, engaging in a share exchange, share
reconstruction and amalgamation, purchasing all or substantially
all of the assets of, entering into contractual arrangements, or
engaging in any other similar business combination with one or more
businesses or entities. LOAC is contemplating a proposed business
combination with 4D Pharma PLC, a public limited company
incorporated under the laws of England and Wales pursuant to an agreement and plan of
merger dated October 21, 2020 as
disclosed in a Form 8-K filed with the Securities and Exchange
Commission on October 22, 2020. LOAC
is sponsored by Whale Management Corporation, a BVI business
company with limited liability.
Forward-Looking Statements
This press release and the exhibits hereto include
"forward-looking statements" within the meaning of the safe harbor
provisions of the U.S. Private Securities Litigation Reform Act of
1995 and within the meaning of Section 27a of the Securities Act of
1933, as amended, and Section 21E of the Securities Exchange Act of
1934, as amended. Any actual results may differ from expectations,
estimates and projections presented or implied and, consequently,
you should not rely on these forward-looking statements as
predictions of future events. Words such as "expect," "estimate,"
"project," "budget," "forecast," "anticipate," "intend," "plan,"
"may," "will," "could," "should," "believes," "predicts,"
"potential," "continue," and similar expressions are intended to
identify such forward-looking statements. These forward-looking
statements include, without limitation, LOAC's expectations with
respect to future performance, anticipated financial impacts of the
proposed business combination, approval of the business combination
transactions by security holders, the satisfaction of the closing
conditions to such transactions and the timing of the completion of
such transactions.
Contact:
Matthew Chen
Longevity Acquisition Corporation
+ (86) 21-60832028
mchen@lonacq.com
View original
content:http://www.prnewswire.com/news-releases/longevity-acquisition-corporation-regains-compliance-with-nasdaq-listing-requirement-301190991.html
SOURCE Longevity Acquisition Corporation